- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.09. | Privia Health CEO sells over $2.5m in company stock | 1 | Investing.com | ||
| 26.08. | Privia Health PT raised on strong revenue outlook | 1 | Investing.com | ||
| 14.08. | Key Takeaways From Privia Health Gr Analyst Ratings | 1 | Benzinga.com | ||
| 09.08. | Earnings call: Privia Health reports robust Q2 2024 financial growth | 1 | Investing.com | ||
| 08.08. | Privia Health target raised to $22 on steady execution | 1 | Investing.com | ||
| 08.08. | Privia Health Group, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 08.08. | Privia Health Group Non-GAAP EPS of $0.19 beats by $0.01, revenue of $422.3M beats by $10.84M | 2 | Seeking Alpha | ||
| 08.08. | Privia Health Group, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 08.08. | Privia Health Group, Inc.: Privia Health Reports Second Quarter 2024 Financial Results | 303 | GlobeNewswire (Europe) | Strong Execution Across All Business and Financial MetricsRaised Full-Year 2024 Guidance to Mid to High End for All Metrics ARLINGTON, Va., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Privia Health Group... ► Artikel lesen | |
| 11.07. | Privia Health Group, Inc.: Privia Health to Report Second Quarter 2024 Results on Thursday, August 8 | 1 | GlobeNewswire (USA) | ||
| 09.07. | Forecasting The Future: 7 Analyst Projections For Privia Health Gr | 1 | Benzinga.com | ||
| 03.07. | Privia Health Group, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 25.06. | Privia Health Group, Inc.: Privia Receives HFMA's MAP Award for High Performance in Revenue Cycle for Performance Year 2023 | 1 | GlobeNewswire (USA) | ||
| 05.06. | Privia Health Group, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 30.05. | Privia Health Group, Inc.: Privia Health to Participate in the William Blair Growth Stock Conference | 1 | GlobeNewswire (USA) | ||
| 29.05. | Hedge Fund and Insider Trading News: Jim Chanos, Israel Englander, Louis Bacon, Philippe Laffont, Millennium Management, Privia Health Group Inc (PRVA), ProFrac Holding Corp (ACDC), and More | 2 | Insider Monkey | ||
| 23.05. | Privia Health Group, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.05. | What 12 Analyst Ratings Have To Say About Privia Health Gr | 2 | Benzinga.com | ||
| 09.05. | Privia Health Group, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 09.05. | Privia Health Group, Inc. - 8-K, Current Report | 1 | SEC Filings |
Seite:
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| UNITEDHEALTH | 519,00 | +0,39 % | Dividendenbekanntmachungen (16.09.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALTAGAS LTD CA0213611001 0,2975 CAD 0,1977 EUR ALTAGAS LTD PRF.G CA0213618865 0,2651 CAD 0,1761 EUR ALTRIA GROUP INC US02209S1033 1... ► Artikel lesen | |
| EMEIS | 6,985 | -2,74 % | Jean-Marc Boursier Appointed emeis' Chief Financial Officer | Regulatory News:
emeis (Paris:EMEIS):
Effective 2 September, Jean-Marc Boursier joins Laurent Guillot and his management team as Group Chief Financial Officer (CFO). Jean-Marc will take over... ► Artikel lesen | |
| NANO-X IMAGING | 6,320 | 0,00 % | Nano-X Imaging LTD.: Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium | HealthCCSng V2.0 introduces additional 'zero calcium' categorization of coronary artery calcium (CAC) and generates a numerical calcium score with corresponding CAC detection category output Marks... ► Artikel lesen | |
| BUTTERFLY NETWORK | 1,910 | 0,00 % | Butterfly Network behält Buy-Rating von TD Cowen mit stabilem Kursziel | ||
| GOODRX | 7,085 | 0,00 % | GoodRx Reports Second Quarter 2024 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading prescription savings platform in the U.S., has released... ► Artikel lesen | |
| JOINT CORP | 11,910 | 0,00 % | The Joint Corp. to Participate in the 7th Annual B. Riley Securities Consumer & TMT Conference | ||
| CARMAT | 1,754 | -2,01 % | CARMAT Launches a Capital Increase for an Initial Amount of €10.3 Million to Finance Its Activities Until at Least the End of 2024 | This capital increase will be carried out through a public offering without preferential subscription rights and with a 7 trading days priority period, on an irreducible and reducible basis,... ► Artikel lesen | |
| HYPERFINE | 1,050 | 0,00 % | Hyperfine, Inc.: Hyperfine Expands European Market Reach with Additional Strategic Distributor Partners | New distribution partnerships further global expansion plans for the Swoop system, growing the reach of Hyperfine to a total of twelve European countries
Hyperfine (Nasdaq: HYPR), the groundbreaking... ► Artikel lesen | |
| MIMEDX | 6,230 | 0,00 % | MiMedx Group, Inc: MIMEDX Announces Second Quarter 2024 Operating and Financial Results | Net Sales of $87 Million Grew 7% Year-Over-Year for the Second Quarter Second Quarter GAAP Net Income and Earnings Per Share were $18 Million and $0.12, Respectively Second Quarter Adjusted EBITDA... ► Artikel lesen | |
| PROGYNY | 16,440 | 0,00 % | Jefferies senkt Kursziel für Progyny auf 24 US-Dollar, hält aber an Kaufempfehlung fest | ||
| PROCEPT BIOROBOTICS | 82,81 | 0,00 % | Procept BioRobotics EVP and CFO sells over $2 million in stock | ||
| BIOMERICA | 0,318 | 0,00 % | Biomerica, Inc.: Biomerica Reports Fiscal 2024 Year End Results | Total Revenue Increases 1% Year-Over-Year - Core Revenue Excluding COVID Tests Climbs 5%, Reflecting Stronger GrowthSignificant Cost Savings Plan Implemented After Year End - Expected to Deliver Expense... ► Artikel lesen | |
| ATRICURE | 28,850 | 0,00 % | Here's Why TimesSquare Capital U.S. Small Cap Growth Strategy Decided to Sell AtriCure (ATRC) | ||
| PROPHASE LABS | 2,180 | +0,93 % | ProPhase Labs, Inc.: ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. - Updated | Pharmaloz Manufacturing explores strategic alternatives, including potential sale. Company announces major strategic AI initiative, Project ZenQ-AI, leveraging its massive global genomics database... ► Artikel lesen | |
| TALKSPACE | 2,095 | 0,00 % | Talkspace CFO acquires shares worth over $148,000 |
Das Unternehmen PRIVIA HEALTH GROUP INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 19,430 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PRIVIA HEALTH GROUP INC finden Sie auf Wallstreet Online.
